Powe, Desmond G <br/><br/>
Beta-blocker drug therapy reduces secondary cancer formation in breast cancer and improves cancer specific survival.  [electronic resource] 

 -  Oncotarget  Nov 2010 
 - 628-638 p.  digital 
<br/><br/> Publication Type: Comparative Study; Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.197  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenergic beta-Antagonists--pharmacology<br/>Adult<br/>Aged<br/>Breast Neoplasms--complications<br/>Carcinoma--complications<br/>Disease-Free Survival<br/>Down-Regulation--drug effects<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Hypertension--complications<br/>Middle Aged<br/>Neoplasm Metastasis<br/>Neoplasm Recurrence, Local--prevention & control<br/>Survival Analysis<br/>Treatment Outcome